These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5407242)

  • 1. [Clinical and laboratory findings in 470 patients with calcilithiasis of the upper urinary tract].
    Kollwitz AA; Kracht H; Brauer R; Löhe E
    Urol Int; 1969; 24(4):318-29. PubMed ID: 5407242
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity products in stone-forming and non-stone-forming urine.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1968 Jun; 34(3):579-94. PubMed ID: 5666884
    [No Abstract]   [Full Text] [Related]  

  • 3. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of the recurrence of urinary lithiasis: mineral waters with high or low calcium content?].
    Sommariva M; Rigatti P; Viola MR
    Minerva Med; 1987 Dec; 78(24):1823-9. PubMed ID: 3431728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC
    Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical concepts of renal calculous disease.
    Thomas WC
    J Urol; 1975 Apr; 113(4):423-32. PubMed ID: 235028
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary calcium, magnesium, crystals and stones in paraplegia.
    Burr RG
    Paraplegia; 1972 May; 10(1):56-63. PubMed ID: 5039329
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dietary food fiber supplements in the treatment of absorptive calciuria].
    Tizzani A; Casetta G; Vercelli D; Piana P
    Minerva Urol Nefrol; 1987; 39(3):225-33. PubMed ID: 2830679
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrolithiasis.
    Williams HE
    N Engl J Med; 1974 Jan; 290(1):33-8. PubMed ID: 4808499
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variations of blood and urinary constituents in renal stone formers.
    Singh RK; Bansal A; Bansal SK; Rai SP
    Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
    [No Abstract]   [Full Text] [Related]  

  • 13. [A metabolic study of urolithiasis. Specificity, sensitivity, efficacy and reproducibility].
    Campoy Martínez P; Reina Ruiz C; Salazar Murillo R; Quintero Rodríguez R; Espinosa Olmedo FJ; García Pérez M
    Ann Urol (Paris); 1995; 29(6-7):337-45. PubMed ID: 8687169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary excretion of citric, hippuric, and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease.
    Elliot JS; Ribeiro ME
    Invest Urol; 1972 Jul; 10(1):102-6. PubMed ID: 5037965
    [No Abstract]   [Full Text] [Related]  

  • 15. The urinary calcium-magnesium ratio in calcigerous stone formers.
    King JS; O'Connor FJ; Smith MJ; Crouse L
    Invest Urol; 1968 Jul; 6(1):60-5. PubMed ID: 5663560
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthophosphate treatment of calcium lithiasis associated with idiopathic hypercalciuria.
    Oliver I; Weinberger A; Bar-Meir S; Sperling O; Jahav J; de Vries A
    Urol Int; 1974; 29(6):414-20. PubMed ID: 4439552
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium on renal lithiasis. Renal lithiasis in review.
    Finlayson B
    Urol Clin North Am; 1974 Jun; 1(2):181-212. PubMed ID: 4372765
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic and glucose load studies in uric acid, oxalic and hyperparathyroid stone formers.
    Schwille PO; Scholz D; Hagemann G; Sigel A
    Adv Exp Med Biol; 1974; 41():485-94. PubMed ID: 4832572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental investigation on the possibility of influencing the solubility of mineral renal stones].
    Knappwost A; Matouschek E
    Urol Int; 1973; 28(1):9-20. PubMed ID: 4693759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.